Paul E. Bendheim
Minden BioPharmaceuticals
Ltd, Jerusalem
Israel
Name/email consistency: high
- Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease. Bendheim, P.E., Poeggeler, B., Neria, E., Ziv, V., Pappolla, M.A., Chain, D.G. J. Mol. Neurosci. (2002)